We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

204 hedge funds and large institutions have $2.2B invested in Bio-Rad Laboratories Class A in 2014 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 80 increasing their positions, 57 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

691% more call options, than puts

Call options by funds: $1.8M | Put options by funds: $227K

50% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 22

40% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 57

6% more funds holding

Funds holding: 193 → 204 (+11)

1.25% more ownership

Funds ownership: 76.44% → 77.69% (+1.2%)

4% less capital invested

Capital invested by funds: $2.31B → $2.2B (-$101M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
204
Holders Change
+11
Holders Change %
+5.7%
% of All Funds
5.86%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
33
Increased
80
Reduced
57
Closed
22
Calls
$1.8M
Puts
$227K
Net Calls
+$1.57M
Net Calls Change
+$1.28M

Top Buyers

1
Norges Bank
Norges Bank
Norway
+$18.9M
2
RRAM
River Road Asset Management
Kentucky
+$14.2M
3
TSW
Thompson Siegel & Walmsley
Virginia
+$14M
4
NFA
Nationwide Fund Advisors
Ohio
+$12.2M
5
NIMC
NWQ Investment Management Company
California
+$11M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$24.4M
2
TM
Tikvah Management
North Carolina
-$12.2M
3
KCM
Kennedy Capital Management
Missouri
-$10.9M
4
First Trust Advisors
First Trust Advisors
Illinois
-$8.15M
5
RA
Royce & Associates
New York
-$7.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
26
Polar Asset Management Partners
Ontario, Canada
$21.4M +$1.83M +15,000 +9%
ICOM
27
Investment Counselors of Maryland
Maryland
$21.4M -$1.19M -9,711 -5%
EARNEST Partners
28
EARNEST Partners
Georgia
$20.6M -$604K -4,948 -3%
Millennium Management
29
Millennium Management
New York
$20M +$609K +4,987 +3%
Charles Schwab
30
Charles Schwab
California
$18.5M +$178K +1,457 +1%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$17.3M +$1.99M +16,297 +13%
Ameriprise
32
Ameriprise
Minnesota
$16.3M -$87.2K -714 -0.5%
SAM
33
Sentinel Asset Management
Vermont
$15.6M +$37.9K +310 +0.2%
Fidelity Investments
34
Fidelity Investments
Massachusetts
$15.3M -$24.4M -199,459 -61%
RRAM
35
River Road Asset Management
Kentucky
$13.9M +$14.2M +116,323 New
VOYA Investment Management
36
VOYA Investment Management
Georgia
$12.8M -$1.35M -11,076 -9%
Geode Capital Management
37
Geode Capital Management
Massachusetts
$12.7M -$60.2K -493 -0.5%
NFA
38
Nationwide Fund Advisors
Ohio
$12M +$12.2M +99,960 New
GI
39
GAMCO Investors
Connecticut
$11.2M -$171K -1,400 -1%
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$10.9M -$1.82M -14,895 -14%
CRCP
41
Copper Rock Capital Partners
Massachusetts
$10.8M +$389K +3,187 +4%
First Trust Advisors
42
First Trust Advisors
Illinois
$9.06M -$8.15M -66,721 -47%
Jacobs Levy Equity Management
43
Jacobs Levy Equity Management
New Jersey
$8.61M -$57.4K -470 -0.6%
TRSOTSOK
44
Teachers Retirement System of the State of Kentucky
Kentucky
$8.43M -$61.1K -500 -0.7%
TCIM
45
TIAA CREF Investment Management
New York
$8.15M -$1.77M -14,493 -18%
Morgan Stanley
46
Morgan Stanley
New York
$8.04M +$2.37M +19,374 +41%
SGA
47
Sector Gamma AS
Norway
$7.94M +$781K +6,400 +11%
EAM
48
Eagle Asset Management
Florida
$7.58M -$298K -2,439 -4%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$7.52M -$97.7K -800 -1%
Renaissance Technologies
50
Renaissance Technologies
New York
$7.36M +$3.87M +31,730 +107%
1
2
3 4 5

BIO Hedge Fund Activity: Q2 2014 in Review

204 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2014, worth a combined $2.2B — down 4.4% from $2.31B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new BIO positions and 22 closed out — a net gain of 11 holders — while 80 added to existing stakes and 57 trimmed.

The largest buyer was Norges Bank, adding an estimated $18.9M. The largest seller was Fidelity Investments, cutting an estimated $24.4M.

  • 204 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2014, up from 193 in Q1 2014.
  • Funds reported $2.2B of Bio-Rad Laboratories Class A stock for Q2 2014, down 4.4% quarter-over-quarter.
  • 33 funds opened new Bio-Rad Laboratories Class A positions in Q2 2014 and 22 closed out, a net change of +11 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q2 2014 was Norges Bank, an estimated $18.9M added.
  • The largest Bio-Rad Laboratories Class A seller in Q2 2014 was Fidelity Investments, an estimated $24.4M sold.

Based on aggregated 13F filings for Q2 2014.